Novo Nordisk and Gilead team up to test fatty liver disease treatment

Novo Nordisk and Gilead Sciences will join forces on a clinical trial combining drugs from the two pharmaceutical firms to treat a progressive fatty liver disease known as NASH.

from Reuters: Health News https://reut.rs/2UR8qhA
via IFTTT